Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Invested Capital: 2011-2012

Historic Invested Capital for Sonoma Pharmaceuticals (SNOA) over the last 2 years, with Dec 2012 value amounting to $6.2 million.

  • Sonoma Pharmaceuticals' Invested Capital rose 456.37% to $6.2 million in Q4 2012 from the same period last year, while for Dec 2012 it was $6.2 million, marking a year-over-year increase of 456.37%. This contributed to the annual value of $547,000 for FY2012, which is 79.03% down from last year.
  • Sonoma Pharmaceuticals' Invested Capital amounted to $6.2 million in Q4 2012, which was up 486.01% from $1.1 million recorded in Q3 2012.
  • In the past 5 years, Sonoma Pharmaceuticals' Invested Capital registered a high of $6.2 million during Q4 2012, and its lowest value of $547,000 during Q1 2012.
  • Its 2-year average for Invested Capital is $1.9 million, with a median of $1.1 million in 2011.
  • Data for Sonoma Pharmaceuticals' Invested Capital shows a peak YoY increase of 456.37% (in 2012) and a maximum YoY decrease of 79.03% (in 2012) over the last 5 years.
  • Sonoma Pharmaceuticals' Invested Capital (Quarterly) stood at $1.1 million in 2011, then spiked by 456.37% to $6.2 million in 2012.
  • Its Invested Capital stands at $6.2 million for Q4 2012, versus $1.1 million for Q3 2012 and $1.8 million for Q2 2012.